In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
Abstract The disulfide isomerase ERp57, originally found in the endoplasmic reticulum, is located in multiple cellular compartments, participates in diverse cell functions and interacts with a huge network of binding partners. It was recently suggested as an attractive new target for cancer therapy...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/70c99fc6b9384a9d8053fe7ddefd8962 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:70c99fc6b9384a9d8053fe7ddefd8962 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:70c99fc6b9384a9d8053fe7ddefd89622021-12-02T14:23:18ZIn oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway10.1038/s41598-021-86658-52045-2322https://doaj.org/article/70c99fc6b9384a9d8053fe7ddefd89622021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-86658-5https://doaj.org/toc/2045-2322Abstract The disulfide isomerase ERp57, originally found in the endoplasmic reticulum, is located in multiple cellular compartments, participates in diverse cell functions and interacts with a huge network of binding partners. It was recently suggested as an attractive new target for cancer therapy due to its critical role in tumor cell proliferation. Since a major bottleneck in cancer treatment is the occurrence of hypoxic areas in solid tumors, the role of ERp57 in cell growth was tested under oxygen depletion in the colorectal cancer cell line HCT116. We observed a severe growth inhibition when ERp57 was knocked down in hypoxia (1% O2) as a consequence of downregulated c-Myc, PLK1, PDPK1 (PDK1) and AKT (PKB). Further, irradiation experiments revealed also a radiosensitizing effect of ERp57 depletion under oxygen deprivation. Compared to ERp57, we do not favour PDPK1 as a suitable pharmaceutical target as its efficient knockdown/chemical inhibition did not show an inhibitory effect on proliferation.Tobias OcklenburgFabian NeumannAlexandra WolfJulia VogelKirsten GöpeltMelanie BaumannJennifer BaumannPhilip KranzEric MetzenUlf BrockmeierNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Tobias Ocklenburg Fabian Neumann Alexandra Wolf Julia Vogel Kirsten Göpelt Melanie Baumann Jennifer Baumann Philip Kranz Eric Metzen Ulf Brockmeier In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway |
description |
Abstract The disulfide isomerase ERp57, originally found in the endoplasmic reticulum, is located in multiple cellular compartments, participates in diverse cell functions and interacts with a huge network of binding partners. It was recently suggested as an attractive new target for cancer therapy due to its critical role in tumor cell proliferation. Since a major bottleneck in cancer treatment is the occurrence of hypoxic areas in solid tumors, the role of ERp57 in cell growth was tested under oxygen depletion in the colorectal cancer cell line HCT116. We observed a severe growth inhibition when ERp57 was knocked down in hypoxia (1% O2) as a consequence of downregulated c-Myc, PLK1, PDPK1 (PDK1) and AKT (PKB). Further, irradiation experiments revealed also a radiosensitizing effect of ERp57 depletion under oxygen deprivation. Compared to ERp57, we do not favour PDPK1 as a suitable pharmaceutical target as its efficient knockdown/chemical inhibition did not show an inhibitory effect on proliferation. |
format |
article |
author |
Tobias Ocklenburg Fabian Neumann Alexandra Wolf Julia Vogel Kirsten Göpelt Melanie Baumann Jennifer Baumann Philip Kranz Eric Metzen Ulf Brockmeier |
author_facet |
Tobias Ocklenburg Fabian Neumann Alexandra Wolf Julia Vogel Kirsten Göpelt Melanie Baumann Jennifer Baumann Philip Kranz Eric Metzen Ulf Brockmeier |
author_sort |
Tobias Ocklenburg |
title |
In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway |
title_short |
In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway |
title_full |
In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway |
title_fullStr |
In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway |
title_full_unstemmed |
In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway |
title_sort |
in oxygen-deprived tumor cells erp57 provides radioprotection and ensures proliferation via c-myc, plk1 and the akt pathway |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/70c99fc6b9384a9d8053fe7ddefd8962 |
work_keys_str_mv |
AT tobiasocklenburg inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway AT fabianneumann inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway AT alexandrawolf inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway AT juliavogel inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway AT kirstengopelt inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway AT melaniebaumann inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway AT jenniferbaumann inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway AT philipkranz inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway AT ericmetzen inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway AT ulfbrockmeier inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway |
_version_ |
1718391432412135424 |